# Lacidipine in Medical Practice in Patients With Mild to Moderate Essential Hypertension

> **NCT02177331** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 53 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Lacidipine

## Key facts

- **NCT ID:** NCT02177331
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-06
- **Primary completion:** 1998-01
- **Final completion:** —
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2014-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02177331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02177331, "Lacidipine in Medical Practice in Patients With Mild to Moderate Essential Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02177331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*